Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Motoyasu Miura, Shinya Uchida, Shimako Tanaka, Chiaki Kamiya, Naoki Katayama, Akio Hakamata, Keiichi Odagiri, Naoki Inui, Junichi Kawakami, Hiroshi Watanabe & Noriyuki Namiki. (2021) Verification of a cocktail approach for quantitative drug–drug interaction assessment: a comparative analysis between the results of a single drug and a cocktail drug. Xenobiotica 51:4, pages 404-412.
Read now
Read now
Jalal Soubhye, Pierre Van Antwerpen & François Dufrasne. (2020) A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019). Expert Opinion on Therapeutic Patents 30:8, pages 595-608.
Read now
Read now
Articles from other publishers (6)
Tord Inghardt, Thomas Antonsson, Cecilia Ericsson, Daniel Hovdal, Petra Johannesson, Carina Johansson, Ulrik Jurva, Johan Kajanus, Bengt Kull, Erik Michaëlsson, Anna Pettersen, Tove Sjögren, Henrik Sörensen, Kristina Westerlund & Eva-Lotte Lindstedt. (2022) Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction. Journal of Medicinal Chemistry 65:17, pages 11485-11496.
Crossref
Crossref
Sophie L. Maiocchi, Jacqueline Ku, Thuan Thai, Enoch Chan, Martin D. Rees & Shane R. Thomas. (2021) Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease. Pharmacology & Therapeutics 221, pages 107711.
Crossref
Crossref
Congrong Niu, Yujin Wang, Xiaofeng Zhao, Sam Tep, Eisuke Murakami, Raju Subramanian, Bill Smith & Yurong Lai. (2019) Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo. Drug Metabolism and Disposition 47:12, pages 1433-1442.
Crossref
Crossref
Camilla Bernasconi, Olavi Pelkonen, Tommy B. Andersson, Judy Strickland, Iwona Wilk-Zasadna, David Asturiol, Thomas Cole, Roman Liska, Andrew Worth, Ursula Müller-Vieira, Lysiane Richert, Christophe Chesne & Sandra Coecke. (2019) Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study. Toxicology in Vitro 60, pages 212-228.
Crossref
Crossref
Tingting Li, Sida Jiang, Bingwei Ni, Qiuji Cui, Qinan Liu & Hongping Zhao. (2019) Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018. International Journal of Molecular Sciences 20:18, pages 4513.
Crossref
Crossref
Alexander V. Dmitriev, Alexey A. Lagunin, Dmitry А. Karasev, Anastasia V. Rudik, Pavel V. Pogodin, Dmitry A. Filimonov & Vladimir V. Poroikov. (2019) Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes. Current Topics in Medicinal Chemistry 19:5, pages 319-336.
Crossref
Crossref